top of page

Mayo Clinic researchers find ‘sugar coating’ cells can protect those typically destroyed in type 1 diabetes

An immunofluorescence microscopy image shows a cluster of insulin-producing beta cells (green) under attack by immune cells (dense cluster of blue dots) in a preclinical model of type 1 diabetes.
An immunofluorescence microscopy image shows a cluster of insulin-producing beta cells (green) under attack by immune cells (dense cluster of blue dots) in a preclinical model of type 1 diabetes.

Researchers at Mayo Clinic have discovered something pretty fascinating: a trick that cancer cells use to hide from the immune system might be repurposed to protect insulin-producing cells in people with type 1 diabetes. Normally, in type 1 diabetes, the immune system mistakenly sees pancreatic beta cells—the ones that make insulin—as invaders and attacks them. The team thought, what if you could shield those beta cells in the same way cancer cells cloak themselves?


Cancer cells often display a sugar molecule called sialic acid on their surfaces; this “sugar coating” helps them look less foreign to immune defenses. The Mayo team focused on an enzyme called ST8Sia6, which increases the amount of that sugar coating. In their experiments with animal models that naturally develop type 1 diabetes, they engineered beta cells so they would produce this enzyme themselves.


The results were impressive: roughly 90% of the time, those engineered cells were able to survive the autoimmune assault that usually destroys beta cells. What’s even more interesting is that the immune system remained otherwise active—it wasn’t suppressed overall, just didn’t attack the modified beta cells. That suggests this is a targeted form of protection rather than blunt immunosuppression, which carries more risks.


Of course, this is early-stage, preclinical research. There’s still a lot of work to be done before this could be used in people, particularly to figure out if transplantable beta cells with this modification can be used without requiring lifetime immunosuppression. But it’s a hopeful step toward therapies that might more precisely protect the insulin-making cells, possibly reducing some of the burdens and side effects of current treatments for type 1 diabetes.


Read the full article on the Mayo Clinic website HERE.


About Direct Diabetes

Direct Diabetes has been helping people with diabetes for 30 years by mailing the supplies they need directly to their home, and helping them avoid the hassle of having to go to a pharmacy. From Continuous Glucose Monitors (CGMs) to insulin pumps and other testing supplies, our goal is to take the stress out of managing diabetes so patients can focus on living healthier, fuller lives. We work directly with doctors and insurance companies to make the process simple and affordable—and we’re proud to be a trusted partner in the diabetes community.


📞 Contact Us: 480-998-5551


🌐 Website: DirectDiabetes.com


📲 Follow Us:

 
 

Connect With Us!

Check out our social media channels for helpful diabetic news and recipes.

  • Youtube
  • TikTok
  • Instagram
  • Facebook
  • X
Direct Diabetes logo - green and blue circle with words underneath

10643 N. Frank Lloyd Wright Blvd, Suite 102

Scottsdale, Arizona, 85259

480-998-5551

1-888-880-8378

Business Hours:
Monday-Friday
8am-4pm

  • Instagram
  • Youtube
  • Facebook
  • TikTok
  • Spotify
  • Apple Music
  • Amazon

© Direct Diabetes

bottom of page